![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
|
PDF
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB |
| Item Type: | Article |
|---|---|
| Title: | Quantitative proteomic analysis of Parkin substrates in Drosophila neurons |
| Creators Name: | Martinez, A. and Lectez, B. and Ramirez, J. and Popp, O. and Sutherland, J.D. and Urbe, S. and Dittmar, G. and Clague, M.J. and Mayor, U. |
| Abstract: | BACKGROUND: Parkin (PARK2) is an E3 ubiquitin ligase that is commonly mutated in Familial Parkinson's Disease (PD). In cell culture models, Parkin is recruited to acutely depolarised mitochondria by PINK1. PINK1 activates Parkin activity leading to ubiquitination of multiple proteins, which in turn promotes clearance of mitochondria by mitophagy. Many substrates have been identified using cell culture models in combination with depolarising drugs or proteasome inhibitors, but not in more physiological settings. METHODS: Here we utilized the recently introduced BioUb strategy to isolate ubiquitinated proteins in flies. Following Parkin Wild-Type (WT) and Parkin Ligase dead (LD) expression we analysed by mass spectrometry and stringent bioinformatics analysis those proteins differentially ubiquitinated to provide the first survey of steady state Parkin substrates using an in vivo model. We further used an in vivo ubiquitination assay to validate one of those substrates in SH-SY5Y cells. RESULTS: We identified 35 proteins that are more prominently ubiquitinated following Parkin over-expression. These include several mitochondrial proteins and a number of endosomal trafficking regulators such as v-ATPase sub-units, Syx5/STX5, ALiX/PDCD6IP and Vps4. We also identified the retromer component, Vps35, another PD-associated gene that has recently been shown to interact genetically with parkin. Importantly, we validated Parkin-dependent ubiquitination of VPS35 in human neuroblastoma cells. CONCLUSIONS: Collectively our results provide new leads to the possible physiological functions of Parkin activity that are not overtly biased by acute mitochondrial depolarisation. |
| Keywords: | Parkin (PARK2), Parkin Substrates, Ubiquitination, VPS35, Neurodegeneration, In Vivo, Parkinson's Disease (PD), Alzheimer's Disease (AD), Label Free Quantification (LFQ), Animals, Drosophila Melanogaster |
| Source: | Molecular Neurodegeneration |
| ISSN: | 1750-1326 |
| Publisher: | BioMed Central |
| Volume: | 12 |
| Number: | 1 |
| Page Range: | 29 |
| Date: | 11 April 2017 |
| Official Publication: | https://doi.org/10.1186/s13024-017-0170-3 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
Download Statistics
Download Statistics
